News | March 09, 2023
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Subscribe To Our Newsletter & Stay Updated
